All News
ICYMI: STAT Report Reveals How Drugmakers ‘Stymie Competition’ & ‘Drive Up the Cost of Medicines’
A new report by STAT sheds additional light on how drugmakers relentlessly abuse the patent system to “stymie competition.
Sticker Shock: New Research Shows an Average List Price Increase of Over 200% for Top Part D Drugs
Research released by AARP’s Public Policy Institute (PPI), list prices for the top 25 Medicare Part D drugs have increased by an average of 226%.